Top Story

Blood transfusions during CABG increased risk for pneumonia

January 30, 2015

Patients had a greater risk for developing postoperative pneumonia if they received red blood cell transfusions during or after isolated CABG surgery, according to data presented at the Society of Thoracic Surgeons Annual Meeting.

“Pneumonia is a known risk following CABG surgery, and developing [pneumonia] has been shown to significantly increase a patient’s risk of morbidity and mortality,” Donald S. Likosky, PhD, associate professor and head of the section of health services research and quality in the department of cardiac surgery at University of Michigan Health System, said in a press release. “Previous research has shown that one in every 20 CABG patients develops a major infection, with pneumonia being the most common type of infection.”

In the Journals

Degree of hypertension control did not affect pregnancy complications

January 30, 2015
In pregnant women, risk for pregnancy loss, high-level neonatal care and overall maternal complications did not differ based on tight control or less-tight control of…
Robert Harrington

Experts provide in-depth analysis of key findings presented at AHA 2014

January 29, 2015
The American Heart Association Scientific Sessions in November featured the presentation of several major studies with practice-changing implications for the field of…
David Frankel, MD, FHRS

Increased use of CRT could help reduce hospitalizations for HF

January 29, 2015
For patients with HF, poor dietary and alcohol choices can lead to increased risk for hospitalization. In fact, recent research has demonstrated that hospitalization for…
Chandan Devireddy, MD, FACC, FSCAI

New specialty designation marks major advance for interventional cardiology

January 29, 2015
It is difficult to briefly summarize the field of interventional cardiology today. From the time of its inception in 1977, interventional cardiologists could offer…
More News Headlines »
CME
Debating the Differences and Nuances of Antiplatelet Therapy in ACS and PCI: Not a One-Size-Fits-All?

Debating the Differences and Nuances of Antiplatelet Therapy in ACS and PCI: Not a One-Size-Fits-All?

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC.

More »
Meeting News Coverage Video
thumbnail for video 3945938325001

Kirk N. Garratt, MD: Prolonged DAPT beneficial in patients with paclitaxel-eluting stents

December 16, 2014
CHICAGO — In this video, Kirk N. Garratt, MD, of the Lennox Hill Hospital, New York, outlines results of a study…
More »
CME
Severe Hypertriglyceridemia: Confronting the Complex Issues in Etiology and Treatment

Severe Hypertriglyceridemia: Confronting the Complex Issues in Etiology and Treatment

This activity is supported by an educational grant from AstraZeneca.

Hypertriglyceridemia is a highly prevalent, yet modifiable, risk factor for atherosclerotic disease, pancreatitis, and…
More »
morganatic-roan